Previous Article | Next Article ![]()
Infection and Immunity, September 2000, p. 5176-5182, Vol. 68, No. 9
Laboratory of Parasitic Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892
Received 28 April 2000/Returned for modification 1 June
2000/Accepted 19 June 2000
A model of cutaneous leishmaniasis using 102
Leishmania major metacyclic promastigotes inoculated into
the footpads of genetically resistant C57BL/6 mice was studied in order
to more accurately reproduce the evolution of lesion formation and the
kinetics of parasite growth and immune response as they might occur in
naturally exposed reservoirs and in human hosts. In contrast to the
more conventional experimental model employing 106
metacyclic promastigotes, in which the rapid development of footpad lesions was associated with an increasing number of amastigotes in the
site, the low-dose model revealed a remarkably "silent" phase of
parasite growth, lasting approximately 6 weeks, during which peak
parasitic loads were established in the absence of any overt pathology.
Footpad swelling was observed after 6 weeks, coincident with the onset
of parasite clearance and with production of high levels of
interleukin-12 (IL-12) and gamma interferon (IFN-
0019-9567/00/$04.00+0
Evolution of Lesion Formation, Parasitic Load,
Immune Response, and Reservoir Potential in C57BL/6 Mice following
High- and Low-Dose Challenge with Leishmania major

) in draining lymph
nodes. Low-dose challenge of IL-12- and IFN-
-depleted or -deficient
mice provided strong evidence that the induction or expression of
cellular immunity is essentially absent during the first 6 to 8 weeks
of intracellular growth, since the concentration of amastigotes in the
site was not enhanced compared to that for wild-type animals during
this time. By monitoring the ability of infected mice to transmit
parasites to vector sand flies, it was observed that following low-dose
challenge, footpads without apparent lesions provided an efficient
source of parasites for exposed flies and that the low-dose challenge
actually extended the duration of parasite transmissibility during the
course of infection.
*
Corresponding author. Mailing address: Laboratory of
Parasitic Diseases, NIAID, Bldg. 4, Rm. 126, Center Dr. MSC 0425, Bethesda, MD 20892-0425. Phone: (301) 496-0577. Fax: (301) 480-3708. E-mail: dsacks{at}nih.gov.
Present address: Department of TB Immunology, Statens Serum
Institut, DK-2300 Copenhagen, Denmark.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»